Global COVID-19 Testing Strategic Business Report 2023 U.S. Market is Estimated at 5.9 Billion, While China is Forecast to Decrease by 30.7 percent CAGR to 2030 - Yahoo Finance
| CODX Stock | USD 0.78 0.06 8.33% |
Slightly above 58% of all Co Diagnostics' investors are looking to take a long position. The analysis of overall sentiment of trading Co Diagnostics stock suggests that some investors are interested at this time. Co Diagnostics' investing sentiment can be driven by a variety of factors including economic data, Co Diagnostics' earnings reports, geopolitical events, and overall market trends.
CODX |
Global COVID-19 Testing Strategic Business Report 2023 U.S. Market is Estimated at 5.9 Billion, While China is Forecast to Decrease by 30.7 percent CAGR to 2030 Yahoo Finance
Read at news.google.com
 |
Co Diagnostics Fundamental Analysis
We analyze Co Diagnostics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Co Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Co Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Co Diagnostics is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Co Diagnostics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Co Diagnostics stock to make a market-neutral strategy. Peer analysis of Co Diagnostics could also be used in its relative valuation, which is a method of valuing Co Diagnostics by comparing valuation metrics with similar companies.
Peers
Co Diagnostics Related Equities
| BMRA | Biomerica | 13.33 | ||||
| BBLG | Bone Biologics | 13.27 | ||||
| NVNO | EnVVeno Medical | 9.45 | ||||
| MOVE | Movano | 7.95 | ||||
| RSLS | ReShape Lifesciences | 6.39 | ||||
| SENS | Senseonics Holdings | 6.38 | ||||
| RPID | Rapid Micro | 5.10 | ||||
| INGN | Inogen | 4.68 | ||||
| TIVC | Tivic Health | 2.94 | ||||
| VVOS | Vivos Therapeutics | 2.82 | ||||
| CLPT | Clearpoint Neuro | 2.25 | ||||
| CVRX | CVRx | 0.44 | ||||
| NPCE | Neuropace | 0.09 | ||||
| SRDX | SurModics | 0.40 | ||||
| NURO | NeuroMetrix | 1.01 | ||||
| IINN | Inspira Technologies | 1.90 | ||||
| HSCS | Heart Test | 2.14 | ||||
| BJDX | Bluejay Diagnostics | 2.62 | ||||
| NAOV | NanoVibronix | 3.23 |
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.